Levolta Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees
Based in Bethlehem, Pa., Levolta Pharmaceuticals features a portfolio of early-stage small molecules and late-stage novel formulated compounds for rheumatology, the central nervous system, oncology and immunology, which the company obtained through the acquisitions of IMC Biotechnology and Renascense Pharmaceuticals. The portfolio is designed to overcome current treatment barriers through an enhanced therapeutic index that drives customer value It's lead product, VOLT01, is a reformulated Zoledronic Acid (ZA) that has demonstrated significantly better safety and efficacy in controlling knee osteoarthritis compared to ZA alone, with the added benefit of no post dosing symptoms. VOLT01 has the potential to be the first Disease-Modifying Drug (DMARD) for osteoarthritis. For more information, please call (848) 702-0682 or visit www.levoltapharma.com.